5.245 Unternehmen passen
Showing 4.101–4.150 of 5.245
| Unternehmen | Note | Kurs | Unter Hoch | KGV | Größe | Rendite | Optionen | Branche |
|---|---|---|---|---|---|---|---|---|
| A | 6,14 $ | -8 % | 12,28 | 63M $ | — | Wöchentlich | Building Products and Equipment | |
| F- | 1,78 $ | -60 % | — | 62,8M $ | — | — | Oil Gas Equipment and Services | |
| B | 2,90 $ | -26 % | — | 62,6M $ | — | Monatlich | Marine Shipping | |
| C- | 1,41 $ | -26 % | — | 62,3M $ | — | — | Advertising Agencies | |
| Ohne Note | 1,45 $ | -52 % | — | 62,1M $ | — | — | Biotechnology | |
| D | 1,18 $ | -28 % | — | 62,1M $ | — | — | Oil Gas E and P | |
| B | 4,55 $ | -77 % | — | 62,1M $ | 17,1 % | — | Engineering and Construction | |
| F- | 0,84 $ | -85 % | — | 61,9M $ | — | Monatlich | Medical Care Facilities | |
| D- | 1,38 $ | -20 % | — | 61,8M $ | — | — | Leisure | |
| Ohne Note | 1,00 $ | -66 % | — | 61,8M $ | — | — | Biotechnology | |
| C+ | 14,54 $ | -13 % | — | 61,7M $ | — | — | Software Application | |
| B- | 0,30 $ | -94 % | — | 61,6M $ | — | Monatlich | Recreational Vehicles | |
| D- | 3,58 $ | -61 % | — | 61,5M $ | — | Monatlich | Biotechnology | |
| Ohne Note | 2,18 $ | -87 % | — | 61,5M $ | — | — | Biotechnology | |
| D | 5,00 $ | -61 % | — | 61,5M $ | — | Monatlich | Medical Devices | |
| A- | 2,35 $ | -90 % | — | 61,5M $ | — | — | Solar | |
| F- | 0,42 $ | -71 % | — | 61,3M $ | — | Monatlich | Engineering and Construction | |
| D | 4,58 $ | -22 % | 16,36 | 60,7M $ | — | Monatlich | Aerospace and Defense | |
| D | 1,04 $ | -100 % | — | 60,4M $ | — | — | Electrical Equipment and Parts | |
| D | 8,68 $ | -46 % | 16,06 | 60,4M $ | — | — | Aerospace and Defense | |
| Ohne Note | 10,22 $ | 0 % | — | 60,2M $ | — | — | Shell Companies | |
| F | 5,77 $ | -30 % | 30,37 | 60,1M $ | — | — | Oil Gas Midstream | |
| B | 5,02 $ | -40 % | 20,06 | 59,9M $ | — | Monatlich | Software Application | |
| C | 44,76 $ | -39 % | — | 59,7M $ | — | Monatlich | Software Infrastructure | |
| Ohne Note | 1,95 $ | -28 % | — | 59,5M $ | — | Monatlich | Biotechnology | |
| F- | 2,38 $ | -76 % | — | 59,4M $ | — | — | Specialty Chemicals | |
| D- | 0,31 $ | -79 % | — | 59,3M $ | — | Monatlich | Biotechnology | |
| B | 2,38 $ | -43 % | — | 59,2M $ | — | — | Luxury Goods | |
| Ohne Note | 2,50 $ | -17 % | — | 59M $ | — | — | Biotechnology | |
| F- | 1,95 $ | -74 % | — | 58,9M $ | — | Monatlich | Electrical Equipment and Parts | |
| F- | 9,35 $ | -35 % | — | 58,8M $ | — | Monatlich | Specialty Retail | |
| Ohne Note | 10,31 $ | -0 % | — | 58,6M $ | — | — | Shell Companies | |
| D | 23,23 $ | -27 % | 10,96 | 58,5M $ | — | — | Personal Services | |
| D- | 3,01 $ | -85 % | — | 58,5M $ | — | Monatlich | Biotechnology | |
| F | 4,96 $ | -40 % | — | 58,5M $ | — | Monatlich | Electronic Gaming and Multimedia | |
| D- | 4,56 $ | -80 % | — | 58,4M $ | — | Monatlich | Biotechnology | |
| B- | 2,04 $ | -37 % | — | 58,2M $ | — | Monatlich | Software Infrastructure | |
| Ohne Note | 10,09 $ | -0 % | — | 58M $ | — | — | Shell Companies | |
| D- | 5,28 $ | -11 % | — | 57,9M $ | — | — | Medical Instruments and Supplies | |
| C | 0,99 $ | -67 % | 7,09 | 57,8M $ | — | Monatlich | Biotechnology | |
| D- | 8,16 $ | -28 % | — | 57,6M $ | — | — | Biotechnology | |
| D- | 5,76 $ | -71 % | — | 57,6M $ | — | Monatlich | Information Technology Services | |
| Ohne Note | 10,98 $ | -0 % | — | 57,5M $ | — | — | Shell Companies | |
| F | 0,65 $ | -80 % | — | 57,4M $ | — | Wöchentlich | Internet Content and Information | |
| Ohne Note | 0,75 $ | -94 % | — | 57,3M $ | — | — | Software Infrastructure | |
| F- | 3,84 $ | -62 % | — | 56,9M $ | — | Monatlich | Capital Markets | |
| D | 3,50 $ | -98 % | 236,66 | 56,9M $ | — | — | Engineering and Construction | |
| F- | 0,73 $ | -77 % | — | 56,6M $ | — | Monatlich | Biotechnology | |
| D- | 2,78 $ | -58 % | — | 56,5M $ | — | Monatlich | Aerospace and Defense | |
| C | 3,91 $ | -62 % | — | 56,3M $ | — | Monatlich | Biotechnology |
Ein Filter ist keine Empfehlung. Jede Zeile hat die genannte Bedingung erfüllt und sonst nichts — InspectStocks beschreibt Unternehmen anhand ihrer eigenen SEC-Einreichungen und rät weder zum Kauf noch zum Verkauf.